These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1559588)

  • 21. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications.
    Hedner J; Darpö B; Ejnell H; Carlson J; Caidahl K
    Eur Respir J; 1995 Feb; 8(2):222-9. PubMed ID: 7758555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective polysomnographic study on the evolution of complex sleep apnoea.
    Cassel W; Canisius S; Becker HF; Leistner S; Ploch T; Jerrentrup A; Vogelmeier C; Koehler U; Heitmann J
    Eur Respir J; 2011 Aug; 38(2):329-37. PubMed ID: 21464115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea.
    Narkiewicz K; Kato M; Phillips BG; Pesek CA; Davison DE; Somers VK
    Circulation; 1999 Dec; 100(23):2332-5. PubMed ID: 10587337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure.
    Krieger J; Laks L; Wilcox I; Grunstein RR; Costas LJ; McDougall JG; Sullivan CE
    Clin Sci (Lond); 1989 Oct; 77(4):407-11. PubMed ID: 2530023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of nasal CPAP treatment on plasma volume, aldosterone and 24-h blood pressure in obstructive sleep apnoea.
    Saarelainen S; Hasan J; Siitonen S; Seppälä E
    J Sleep Res; 1996 Sep; 5(3):181-5. PubMed ID: 8956208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular ejection fraction in obstructive sleep apnea. Effects of long-term treatment with nasal continuous positive airway pressure.
    Krieger J; Grucker D; Sforza E; Chambron J; Kurtz D
    Chest; 1991 Oct; 100(4):917-21. PubMed ID: 1914605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy.
    Schulz R; Schmidt D; Blum A; Lopes-Ribeiro X; Lücke C; Mayer K; Olschewski H; Seeger W; Grimminger F
    Thorax; 2000 Dec; 55(12):1046-51. PubMed ID: 11083891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nasal CPAP and weight loss in hypertensive patients with obstructive sleep apnoea.
    Rauscher H; Formanek D; Popp W; Zwick H
    Thorax; 1993 May; 48(5):529-33. PubMed ID: 8322241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year effects of nasal continuous positive airway pressure in obstructive sleep apnoea syndrome.
    Chaouat A; Weitzenblum E; Kessler R; Oswald M; Sforza E; Liegeon MN; Krieger J
    Eur Respir J; 1997 Nov; 10(11):2578-82. PubMed ID: 9426098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea.
    Grimpen F; Kanne P; Schulz E; Hagenah G; Hasenfuss G; Andreas S
    Eur Respir J; 2000 Feb; 15(2):320-5. PubMed ID: 10706499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary excretion of guanosine 3':5'-cyclic monophosphate during sleep in obstructive sleep apnoea patients with and without nasal continuous positive airway pressure treatment.
    Krieger J; Schmidt M; Sforza E; Lehr L; Imbs JL; Coumaros G; Kurtz D
    Clin Sci (Lond); 1989 Jan; 76(1):31-7. PubMed ID: 2537703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Night-to-night variability in CPAP use over the first three months of treatment.
    Weaver TE; Kribbs NB; Pack AI; Kline LR; Chugh DK; Maislin G; Smith PL; Schwartz AR; Schubert NM; Gillen KA; Dinges DF
    Sleep; 1997 Apr; 20(4):278-83. PubMed ID: 9231953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea.
    Krieger J; Follenius M; Sforza E; Brandenberger G; Peter JD
    Clin Sci (Lond); 1991 May; 80(5):443-9. PubMed ID: 1851683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of obstructive sleep apnea with continuous nasal airflow delivered through nasal prongs.
    Wilhoit SC; Brown ED; Suratt PM
    Chest; 1984 Feb; 85(2):170-3. PubMed ID: 6362998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal lipid peroxidation in patients with sleep apnoea.
    Barceló A; Miralles C; Barbé F; Vila M; Pons S; Agustí AG
    Eur Respir J; 2000 Oct; 16(4):644-7. PubMed ID: 11106206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet function in patients with obstructive sleep apnoea syndrome.
    Sanner BM; Konermann M; Tepel M; Groetz J; Mummenhoff C; Zidek W
    Eur Respir J; 2000 Oct; 16(4):648-52. PubMed ID: 11106207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative obstructive sleep apnoea. Haemodynamic effects of treatment with nasal CPAP.
    Reeder MK; Goldman MD; Loh L; Muir AD; Casey KR; Gitlin DA
    Anaesthesia; 1991 Oct; 46(10):849-53. PubMed ID: 1952000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of plasma volume during obstructive sleep apnoea.
    Krieger J
    J Sleep Res; 1995 Jun; 4(S1):107-111. PubMed ID: 10607185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sleep studies in OSA patients before CPAP treatment. One night or two?
    Orr WC
    Chest; 1993 Feb; 103(2):652-3. PubMed ID: 8432185
    [No Abstract]   [Full Text] [Related]  

  • 40. Prolactin secretion during sleep in obstructive sleep apnoea patients.
    Spiegel K; Follenius M; Krieger J; Sforza E; Brandenberger G
    J Sleep Res; 1995 Mar; 4(1):56-62. PubMed ID: 10607142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.